2 completed, 1 enrolling by invitation, 1 terminated, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow TARP: new trials by email Literature Review of TARP trials Research Report on TARP
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Prospective Cohort Study of for Surgical Treatment of Irreducible Atlantoaxial Dislocation Posterior intra-articular distraction and fusion, Anterior transoral release and posterior cantilever reduction and fusion, TARP - Atlantoaxial Dislocation | Unknown | Xuanwu Hospital, Beijing | 100 | 2023-09-01 | 2023-08-23 | |
| Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer Autologus elutriated monocyte placebo vaccine, Multi-epitope (ME) T-cell receptor g alternate reading frame protein (TARP) vaccine - Prostatic Neoplasms, Prostate Cancer | Phase 2 | Terminated | National Cancer Institute (NCI) | 7 | 2015-07-10 | 2022-03-18 |
| Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139 Multi-epitope (ME) T-cell Receptor Alternate Reading Frame Protein (TARP) vaccine - Prostatic Neoplasms, Neoplasms of Prostate | Phase 2 | Completed | National Cancer Institute (NCI) | 14 | 2015-05-12 | 2024-12-10 |
| A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer T-cell receptor alternate reading frame protein (TARP) peptide vaccine, T-cell receptor alternate reading frame protein (TARP) dendritic cell vaccine - Prostate Specific Antigens, Prostate Neoplasms | Phase 1 | Completed | National Cancer Institute (NCI) | 41 | 2009-05-11 | 2022-10-12 |
| Outcomes of Aortic Dissection Repair Conservative Root- Sparing Aortic Valve Resuspension with or without Hemiarch Repair, Extensive Ascending Aorta Replacement (AAR) with Aortic Root Replacement (ARR), Extensive Ascending Aorta Replacement (AAR) with Total Arch Replacement (TARP) - Type A Aortic Dissection, Ascending Aortic Dissection | Enrolling by invitation | Centre Cardiologique du Nord | 1200 | 2005-01-01 | 2026-05-19 |
Prostatic Neoplasms (3) · Aortic Diseases (1) · Aortic Valve Insufficiency (1) · Dissection, Ascending Aorta (1)
National Cancer Institute (NCI) (3) · Centre Cardiologique du Nord (1) · Xuanwu Hospital, Beijing (1)
United States (3) · France (1)
Hoyoung M Maeng, M.D. (3) · Francesco Nappi, MD (1)
PMID 20625143, PMID 23599348, PMID 24124874, PMID 26088302, PMID 30401530, PMID 31974270, PMID 32599034, PMID 34468733, PMID 36001309, PMID 36912033